Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Association of the vitamin D metabolism gene CYP24A1 with coronary artery calcification.

Shen H, Bielak LF, Ferguson JF, Streeten EA, Yerges-Armstrong LM, Liu J, Post W, O'Connell JR, Hixson JE, Kardia SL, Sun YV, Jhun MA, Wang X, Mehta NN, Li M, Koller DL, Hakonarson H, Keating BJ, Rader DJ, Shuldiner AR, Peyser PA, Reilly MP, Mitchell BD.

Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2648-54. doi: 10.1161/ATVBAHA.110.211805.

2.

Is coronary artery calcification at the intersection of vitamin D and coronary artery disease?

Dastani Z, Richards JB.

Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2329-30. doi: 10.1161/ATVBAHA.110.216218. No abstract available.

3.

Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.

Holick CN, Stanford JL, Kwon EM, Ostrander EA, Nejentsev S, Peters U.

Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):1990-9.

4.

Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma.

Kelly JL, Drake MT, Fredericksen ZS, Asmann YW, Liebow M, Shanafelt TD, Feldman AL, Ansell SM, Macon WR, Herr MM, Wang AH, Nowakowski GS, Call TG, Habermann TM, Slager SL, Witzig TE, Cerhan JR.

Cancer Causes Control. 2012 Jul;23(7):1017-29. doi: 10.1007/s10552-012-9967-0.

5.

Vitamin D related genes, CYP24A1 and CYP27B1, and colon cancer risk.

Dong LM, Ulrich CM, Hsu L, Duggan DJ, Benitez DS, White E, Slattery ML, Farin FM, Makar KW, Carlson CS, Caan BJ, Potter JD, Peters U.

Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2540-8. doi: 10.1158/1055-9965.EPI-09-0228.

6.

Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis.

Simon KC, Munger KL, Xing Yang, Ascherio A.

Mult Scler. 2010 Feb;16(2):133-8. doi: 10.1177/1352458509355069.

7.

Asthma and genes encoding components of the vitamin D pathway.

Bossé Y, Lemire M, Poon AH, Daley D, He JQ, Sandford A, White JH, James AL, Musk AW, Palmer LJ, Raby BA, Weiss ST, Kozyrskyj AL, Becker A, Hudson TJ, Laprise C.

Respir Res. 2009 Oct 24;10:98. doi: 10.1186/1465-9921-10-98.

8.

Impaired vitamin D activation and association with CYP24A1 haplotypes in differentiated thyroid carcinoma.

Penna-Martinez M, Ramos-Lopez E, Stern J, Kahles H, Hinsch N, Hansmann ML, Selkinski I, Grünwald F, Vorländer C, Bechstein WO, Zeuzem S, Holzer K, Badenhoop K.

Thyroid. 2012 Jul;22(7):709-16. doi: 10.1089/thy.2011.0330.

9.

Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk.

Reimers LL, Crew KD, Bradshaw PT, Santella RM, Steck SE, Sirosh I, Terry MB, Hershman DL, Shane E, Cremers S, Dworakowski E, Teitelbaum SL, Neugut AI, Gammon MD.

Cancer Causes Control. 2015 Feb;26(2):187-203. doi: 10.1007/s10552-014-0497-9.

10.

Vitamin D pathway gene variants and prostate cancer prognosis.

Holt SK, Kwon EM, Koopmeiners JS, Lin DW, Feng Z, Ostrander EA, Peters U, Stanford JL.

Prostate. 2010 Sep 15;70(13):1448-60. doi: 10.1002/pros.21180.

11.

Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk.

Ahn J, Albanes D, Berndt SI, Peters U, Chatterjee N, Freedman ND, Abnet CC, Huang WY, Kibel AS, Crawford ED, Weinstein SJ, Chanock SJ, Schatzkin A, Hayes RB; Prostate, Lung, Colorectal and Ovarian Trial Project Team..

Carcinogenesis. 2009 May;30(5):769-76. doi: 10.1093/carcin/bgp055.

12.

Candidate gene association study of coronary artery calcification in chronic kidney disease: findings from the CRIC study (Chronic Renal Insufficiency Cohort).

Ferguson JF, Matthews GJ, Townsend RR, Raj DS, Kanetsky PA, Budoff M, Fischer MJ, Rosas SE, Kanthety R, Rahman M, Master SR, Qasim A, Li M, Mehta NN, Shen H, Mitchell BD, O'Connell JR, Shuldiner AR, Ho WK, Young R, Rasheed A, Danesh J, He J, Kusek JW, Ojo AO, Flack J, Go AS, Gadegbeku CA, Wright JT Jr, Saleheen D, Feldman HI, Rader DJ, Foulkes AS, Reilly MP; CRIC Study Principal Investigators..

J Am Coll Cardiol. 2013 Aug 27;62(9):789-98. doi: 10.1016/j.jacc.2013.01.103.

13.

Vitamin D receptor, CYP27B1 and CYP24A1 genes polymorphisms association with oral cancer risk and survival.

Zeljic K, Supic G, Stamenkovic Radak M, Jovic N, Kozomara R, Magic Z.

J Oral Pathol Med. 2012 Nov;41(10):779-87. doi: 10.1111/j.1600-0714.2012.01164.x.

PMID:
22612324
14.

CYP24A1 and CYP27B1 polymorphisms modulate vitamin D metabolism in colon cancer cells.

Jacobs ET, Van Pelt C, Forster RE, Zaidi W, Hibler EA, Galligan MA, Haussler MR, Jurutka PW.

Cancer Res. 2013 Apr 15;73(8):2563-73. doi: 10.1158/0008-5472.CAN-12-4134.

15.

Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study.

Yao S, Zirpoli G, Bovbjerg DH, Jandorf L, Hong CC, Zhao H, Sucheston LE, Tang L, Roberts M, Ciupak G, Davis W, Hwang H, Johnson CS, Trump DL, McCann SE, Ademuyiwa F, Pawlish KS, Bandera EV, Ambrosone CB.

Breast Cancer Res. 2012 Apr 4;14(2):R58.

16.

Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes.

Levin GP, Robinson-Cohen C, de Boer IH, Houston DK, Lohman K, Liu Y, Kritchevsky SB, Cauley JA, Tanaka T, Ferrucci L, Bandinelli S, Patel KV, Hagström E, Michaëlsson K, Melhus H, Wang T, Wolf M, Psaty BM, Siscovick D, Kestenbaum B.

JAMA. 2012 Nov 14;308(18):1898-905. doi: 10.1001/jama.2012.17304.

17.

The relationship between diastolic blood pressure and coronary artery calcification is dependent on single nucleotide polymorphisms on chromosome 9p21.3.

Kim DS, Smith JA, Bielak LF, Wu CY, Sun YV, Sheedy PF 2nd, Turner ST, Peyser PA, Kardia SL.

BMC Med Genet. 2014 Sep 4;15:89. doi: 10.1186/s12881-014-0089-2.

18.

No association of vitamin D metabolism-related polymorphisms and melanoma risk as well as melanoma prognosis: a case-control study.

Schäfer A, Emmert S, Kruppa J, Schubert S, Tzvetkov M, Mössner R, Reich K, Berking C, Volkenandt M, Pföhler C, Schön MP, Vogt T, König IR, Reichrath J.

Arch Dermatol Res. 2012 Jul;304(5):353-61. doi: 10.1007/s00403-012-1243-3.

19.

Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial.

Barry EL, Rees JR, Peacock JL, Mott LA, Amos CI, Bostick RM, Figueiredo JC, Ahnen DJ, Bresalier RS, Burke CA, Baron JA.

J Clin Endocrinol Metab. 2014 Oct;99(10):E2133-7. doi: 10.1210/jc.2014-1389.

20.

No association between type 1 diabetes and genetic variation in vitamin D metabolism genes: a Danish study.

Thorsen SU, Mortensen HB, Carstensen B, Fenger M, Thuesen BH, Husemoen L, Bergholdt R, Brorsson C, Pociot F, Linneberg A, Svensson J.

Pediatr Diabetes. 2014 Sep;15(6):416-21. doi: 10.1111/pedi.12105.

PMID:
24325596
Items per page

Supplemental Content

Support Center